Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy
Open Access
- 4 July 2005
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 130 (2) , 528-537
- https://doi.org/10.1016/j.jtcvs.2004.09.040
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Thymoglobulin: an immunologic overviewCurrent Opinion in Organ Transplantation, 2003
- Homeostatic proliferation is a barrier to transplantation toleranceNature Medicine, 2003
- Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent WeaningAnnals of Surgery, 2003
- RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)Transplantation, 2003
- The registry of the international society for heart and lung transplantation: twentieth official adult lung and heart–lung transplant report—2003Published by Elsevier ,2003
- The complementary roles of deletion and regulation in transplantation toleranceNature Reviews Immunology, 2003
- The enemy within: keeping self-reactive T cells at bay in the peripheryNature Reviews Immunology, 2002
- Transplantation tolerance from a historical perspectiveNature Reviews Immunology, 2001
- Antigen Localization and Migration in Immunity and ToleranceNew England Journal of Medicine, 1998
- Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipientsThe Lancet, 1998